QuantuMDx has developed the Q-POC™ platform, a rapid multiplex PCR testing system designed to deliver fast and accurate diagnostic results at the Point of Care in approximately 30 minutes. This innovative platform is particularly beneficial for infectious disease testing, where timely results are crucial for informing treatment decisions and mitigating the risk of transmission. The Q-POC™ system is portable, user-friendly, and requires minimal hands-on time, making it suitable for a variety of clinical settings, including hospitals, clinics, and pharmacies. Each test is designed to be straightforward, with an intuitive interface that guides users through the testing process, ensuring accessibility even for those without extensive technical training.

The Q-POC™ platform incorporates advanced technology, including intelligent multilingual software algorithms that simplify result interpretation and reporting. It operates without the need for calibration or preventive maintenance, as each test cassette contains all necessary reagents and can be stored at room temperature. The compact design and internal battery allow for flexibility in usage, enabling molecular testing outside traditional laboratory environments. With features that enhance both speed and accuracy, the Q-POC™ platform represents a significant advancement in rapid diagnostics, particularly for respiratory infections, providing reliable results that can be trusted in critical healthcare scenarios.

United States

QuantuMDx is dedicated to improving and democratising global health by providing transformative diagnostics to overburdened healthcare systems, empowering frontline healthworkers with intuitive, rapid, accurate and low cost decentralised testing solutions. COVID-19: CE Mark (06/2020)

QuantuMDx

Company Details